Latest news
Bristol Myers delays Cobenfy Alzheimer’s psychosis readout again amid another quarterly beat - Fierce PharmaFierce Pharma · Thu, 30 Jul 2026 07:00:00 GMTBMS’ ‘big beat’ clouded by Cobenfy, heart disease data delays - BioSpaceBioSpace · Thu, 30 Jul 2026 07:00:00 GMTMapLight CEO on what investors missed in the biotech’s schizophrenia data - BioPharma DiveBioPharma Dive · Wed, 29 Jul 2026 07:00:00 GMTMapLight’s schizophrenia pill remains in Cobenfy’s shadow after mixed Phase 2 readout - BioSpaceBioSpace · Mon, 27 Jul 2026 07:00:00 GMTMapLight dives despite positive data for schizophrenia drug - BioPharma DiveBioPharma Dive · Mon, 27 Jul 2026 07:00:00 GMT